Cargando…

THE PREVALENCE LIVER FUNCTION AND IMMUNOLOGIC STATUS OF CHILDREN WITH HIV AND HEPATITIS B VIRUS COINFECTION IN ENUGU, NIGERIA

BACKGROUND: Hepatitis B Virus (HBV) co-infection is prevalent among HIV infected individuals because of shared routes and mechanisms of transmission. The multidimensional immunosuppression from HIV infection causes impaired spontaneous recovery from an acute HBV infection, predisposing to chronic in...

Descripción completa

Detalles Bibliográficos
Autores principales: Davidson, Uleanya Nwachinemere, Chidiebele, Nwokoye Ikenna, Josephine, Emodi Ifeoma, Olakunle, Obidike Egbuna, Nnaemeka, Ikefuna Anthony, Chijioke, Eze Jude, Kingsley, Ndu Ikenna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: African Traditional Herbal Medicine Supporters Initiative (ATHMSI) 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349760/
https://www.ncbi.nlm.nih.gov/pubmed/28331915
http://dx.doi.org/10.21010/ajid.v10i2.1
_version_ 1782514532933959680
author Davidson, Uleanya Nwachinemere
Chidiebele, Nwokoye Ikenna
Josephine, Emodi Ifeoma
Olakunle, Obidike Egbuna
Nnaemeka, Ikefuna Anthony
Chijioke, Eze Jude
Kingsley, Ndu Ikenna
author_facet Davidson, Uleanya Nwachinemere
Chidiebele, Nwokoye Ikenna
Josephine, Emodi Ifeoma
Olakunle, Obidike Egbuna
Nnaemeka, Ikefuna Anthony
Chijioke, Eze Jude
Kingsley, Ndu Ikenna
author_sort Davidson, Uleanya Nwachinemere
collection PubMed
description BACKGROUND: Hepatitis B Virus (HBV) co-infection is prevalent among HIV infected individuals because of shared routes and mechanisms of transmission. The multidimensional immunosuppression from HIV infection causes impaired spontaneous recovery from an acute HBV infection, predisposing to chronic infection which is worsened by younger age at infection. Co-infection increases the risk of HBV replication, hepatotoxicity and liver related deaths from Highly Active Antiretroviral Therapy (HAART). The study was undertaken to highlight the burden of co-infection among HIV positive children in Enugu, determine the associated risk factors and compare the effect of co-infection between co-infected and non-co-infected children using liver enzyme and CD4 counts. MATERIALS AND METHODS: A cross sectional study was carried out among HIV positive children attending the Paediatric ARV clinic of the University of Nigeria Teaching Hospital, Ituku-Ozalla. A total of 140 HIV infected children aged 18 months to 15 years were recruited. An interviewer questionnaire was administered. Hepatitis B surface antigen (HBsAg) was determined using Determine test Kit. Baseline and recent CD4 counts/CD4% were retrieved from the patients’ folders. RESULTS: Fourteen (10%) were positive for HBsAg. The highest prevalence of HBsAg was observed among children aged 11- 15 years. The higher the socioeconomic class the less likely the HBsAg positivity. Seven (50%) of the co-infected children had elevated baseline ALT compared with 57 (45.2%) of non-co-infected children though the difference was not statistically significant (t = 0.6, P = 0.56). After the initiation of HAART, 10 (76.9%) of the co-infected and 18 (15.1%) of the non-co-infected children had elevated ALT. The baseline median CD4 count among children ≥ 6 years was 230 cells/mm(3) and 360 cells/mm(3) respectively among the co-infected and non- co-infected, (P = 0.67). However, in children ≤ 5 years, it was 25% and 15 % respectively (P = 0.06). CONCLUSION: HBV co-infection among HIV infected children is common in our environment, and co-infection is associated with impaired immunity and probably liver enzyme derangement.
format Online
Article
Text
id pubmed-5349760
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher African Traditional Herbal Medicine Supporters Initiative (ATHMSI)
record_format MEDLINE/PubMed
spelling pubmed-53497602017-05-01 THE PREVALENCE LIVER FUNCTION AND IMMUNOLOGIC STATUS OF CHILDREN WITH HIV AND HEPATITIS B VIRUS COINFECTION IN ENUGU, NIGERIA Davidson, Uleanya Nwachinemere Chidiebele, Nwokoye Ikenna Josephine, Emodi Ifeoma Olakunle, Obidike Egbuna Nnaemeka, Ikefuna Anthony Chijioke, Eze Jude Kingsley, Ndu Ikenna Afr J Infect Dis Article BACKGROUND: Hepatitis B Virus (HBV) co-infection is prevalent among HIV infected individuals because of shared routes and mechanisms of transmission. The multidimensional immunosuppression from HIV infection causes impaired spontaneous recovery from an acute HBV infection, predisposing to chronic infection which is worsened by younger age at infection. Co-infection increases the risk of HBV replication, hepatotoxicity and liver related deaths from Highly Active Antiretroviral Therapy (HAART). The study was undertaken to highlight the burden of co-infection among HIV positive children in Enugu, determine the associated risk factors and compare the effect of co-infection between co-infected and non-co-infected children using liver enzyme and CD4 counts. MATERIALS AND METHODS: A cross sectional study was carried out among HIV positive children attending the Paediatric ARV clinic of the University of Nigeria Teaching Hospital, Ituku-Ozalla. A total of 140 HIV infected children aged 18 months to 15 years were recruited. An interviewer questionnaire was administered. Hepatitis B surface antigen (HBsAg) was determined using Determine test Kit. Baseline and recent CD4 counts/CD4% were retrieved from the patients’ folders. RESULTS: Fourteen (10%) were positive for HBsAg. The highest prevalence of HBsAg was observed among children aged 11- 15 years. The higher the socioeconomic class the less likely the HBsAg positivity. Seven (50%) of the co-infected children had elevated baseline ALT compared with 57 (45.2%) of non-co-infected children though the difference was not statistically significant (t = 0.6, P = 0.56). After the initiation of HAART, 10 (76.9%) of the co-infected and 18 (15.1%) of the non-co-infected children had elevated ALT. The baseline median CD4 count among children ≥ 6 years was 230 cells/mm(3) and 360 cells/mm(3) respectively among the co-infected and non- co-infected, (P = 0.67). However, in children ≤ 5 years, it was 25% and 15 % respectively (P = 0.06). CONCLUSION: HBV co-infection among HIV infected children is common in our environment, and co-infection is associated with impaired immunity and probably liver enzyme derangement. African Traditional Herbal Medicine Supporters Initiative (ATHMSI) 2016-05-01 /pmc/articles/PMC5349760/ /pubmed/28331915 http://dx.doi.org/10.21010/ajid.v10i2.1 Text en Copyright: © 2016 Afr. J. Infect. Diseases http://creativecommons.org/licenses/CC-BY/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
spellingShingle Article
Davidson, Uleanya Nwachinemere
Chidiebele, Nwokoye Ikenna
Josephine, Emodi Ifeoma
Olakunle, Obidike Egbuna
Nnaemeka, Ikefuna Anthony
Chijioke, Eze Jude
Kingsley, Ndu Ikenna
THE PREVALENCE LIVER FUNCTION AND IMMUNOLOGIC STATUS OF CHILDREN WITH HIV AND HEPATITIS B VIRUS COINFECTION IN ENUGU, NIGERIA
title THE PREVALENCE LIVER FUNCTION AND IMMUNOLOGIC STATUS OF CHILDREN WITH HIV AND HEPATITIS B VIRUS COINFECTION IN ENUGU, NIGERIA
title_full THE PREVALENCE LIVER FUNCTION AND IMMUNOLOGIC STATUS OF CHILDREN WITH HIV AND HEPATITIS B VIRUS COINFECTION IN ENUGU, NIGERIA
title_fullStr THE PREVALENCE LIVER FUNCTION AND IMMUNOLOGIC STATUS OF CHILDREN WITH HIV AND HEPATITIS B VIRUS COINFECTION IN ENUGU, NIGERIA
title_full_unstemmed THE PREVALENCE LIVER FUNCTION AND IMMUNOLOGIC STATUS OF CHILDREN WITH HIV AND HEPATITIS B VIRUS COINFECTION IN ENUGU, NIGERIA
title_short THE PREVALENCE LIVER FUNCTION AND IMMUNOLOGIC STATUS OF CHILDREN WITH HIV AND HEPATITIS B VIRUS COINFECTION IN ENUGU, NIGERIA
title_sort prevalence liver function and immunologic status of children with hiv and hepatitis b virus coinfection in enugu, nigeria
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349760/
https://www.ncbi.nlm.nih.gov/pubmed/28331915
http://dx.doi.org/10.21010/ajid.v10i2.1
work_keys_str_mv AT davidsonuleanyanwachinemere theprevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria
AT chidiebelenwokoyeikenna theprevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria
AT josephineemodiifeoma theprevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria
AT olakunleobidikeegbuna theprevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria
AT nnaemekaikefunaanthony theprevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria
AT chijiokeezejude theprevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria
AT kingsleynduikenna theprevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria
AT davidsonuleanyanwachinemere prevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria
AT chidiebelenwokoyeikenna prevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria
AT josephineemodiifeoma prevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria
AT olakunleobidikeegbuna prevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria
AT nnaemekaikefunaanthony prevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria
AT chijiokeezejude prevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria
AT kingsleynduikenna prevalenceliverfunctionandimmunologicstatusofchildrenwithhivandhepatitisbviruscoinfectioninenugunigeria